Microbiological Data for Patients with Febrile Neutropenia

Kanamaru, Akihisa; Tatsumi, Youichi
July 2004
Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS7
Academic Journal
The pattern of bacterial infections and antimicrobial susceptibility has changed significantly during the past 20-30 years. The causative organisms for bacteremia or fungemia identified at Kinki University Hospital in 1985-1996 were compared with the isolates identified during 1997-2002. The prevalence of gram-negative organisms decreased, whereas the prevalence of gram-positive organisms increased. Staphylococcal species predominated in the second period, accounting for 22% of isolates, and methicillin-resistant Staphylococcus aureus (MRSA) increased from 5% to 14% of isolates. Pseudomonas aeruginosa ranked second, although the prevalence decreased in the second period compared with the first. Candida species were also relatively frequent (11%). Enterococcal species had an 8% prevalence. A comparison of all culture isolates showed that gram-negative isolates still predominated among the general patient population, whereas almost equal prevalence was observed in patients with hematological diseases. MRSA was the organism most frequently isolated in the general patient population, followed by P. aeruginosa. Among staphylococcal species, MRSA accounted for as much as 90% of isolates.


Related Articles

  • Changes in the Etiology of Bacteremia in Febrile Neutropenic Patients and the Susceptibilities of the Currently Isolated Pathogens. Ramphal, Reuben // Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS25 

    The etiology of bacteremia in febrile neutropenic patients in the past few decades has shifted from gram-negative to gram-positive organisms. Potential reasons include the use of indwelling catheters, local environ-mental conditions, and the administration of specific antibiotic agents,...

  • Management of the Febrile Neutropenic Patient: A Consensus Conference. Picazo, Juan J. // Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS1 

    Focuses on the use of antimicrobials in patients with febrile neutropenia. Impact of the Infectious Diseases Society of America on the management of febrile neutropenia patients; Etiology of bacteremia in fibrile neutropenic patients; Sources of febrile neutropenia infections.

  • Review: Additional anti-gram-positive antibiotics do not reduce all-cause mortality in cancer and febrile neutropenia.  // ACP Journal Club;Jan/Feb2006, Vol. 144 Issue 1, p3 

    This article reports on a study conducted to examine the efficacy of anti-gram-positive (anti-GP) antibiotics in reducing all-cause mortality in cancer and febrile neutropenia. Randomized or quasi-randomized controlled trials (RCTs) were studied, comparing a standard antibiotic regimen with the...

  • Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Sparrelid, E; Hägglund, H; Remberger, M; Ringdén, O; Lönnqvist, B; Ljungman, P; Andersson, J // Bone Marrow Transplantation;10/15/98, Vol. 22 Issue 8, p795 

    Episodes of bacteraemia during the aplastic phase were studied in 500 allogeneic bone marrow (BMT) recipients, regarding incidence, microbial aetiology, risk factors, mortality and causes of death. One hundred and sixty-four patients (33%) had at least one positive blood culture. Gram-positive...

  • Treating low-risk febrile neutropenia: Jenny's story. Phillips, R.; Skinner, R.; Chisholm, J. C. // Archives of Disease in Childhood;Jan2007, Vol. 92 Issue 1, p7 

    The article discusses varying ways of treating children with low-risk febrile neutropenia. There are centers who treat all episodes of febrile neutropenia using inpatient broad-spectrum intravenous antibiotics. However, there are also studies which suggest that it may be appropriate to reduce...

  • Telavancin in the treatment of invasive Gram-positive infections. Keynan, Yoav; Rubinstein, Ethan // Clinical Audit;2012 Part 2, Vol. 4, p25 

    Telavancin is a newer once-daily lipoglycopeptide with activity against Gram-positive bacteria, including those that are resistant to conventional antibiotics like beta-lactams. The results of recent clinical trials led to registration of telavancin for use in skin and skin structure infections...

  • Tropheryma whipplei Bacteremia during Fever in Rural West Africa. Fenollar, Florence; Mediannikov, Oleg; Socolovschi, Cristina; Bassene, Hubert; Diatta, Georges; Richet, Hervé; Tall, Adama; Sokhna, Cheikh; Trape, Jean-François; Raoult, Didier // Clinical Infectious Diseases;9/1/2010, Vol. 51 Issue 5, p515 

    Background. Tropheryma whipplei not only causes Whipple disease but also is an emerging pathogen associated with gastroenteritis and pneumonia that is commonly detected in stool samples in rural West Africa. We investigated the role of T. whipplei in febrile patients from rural Senegal who had a...

  • A New Piece Added to the Whipple Puzzle: Tropheryma whipplei Primary Infection with Bacteremia and Cough. Greub, Gilbert // Clinical Infectious Diseases;9/1/2010, Vol. 51 Issue 5, p522 

    In this article the author discusses the prevalence of Tropheryma whipplei primary infection. He cites a study which considers bacteremia and cough as the common clinical presentations of acute Tropheryma whipplei infection. He says that the association between Tropheryma whipplei bacteremia and...

  • Association between Antifungal Prophylaxis and Rate of Documented Bacteremia in Febrile Neutropenic Cancer Patients. Viscoli, C.; Paesmans, M.; Sanz, M.; Castagnola, E.; Klastersky, J.; Martino, P.; Glauser, M. // Clinical Infectious Diseases;6/1/2001, Vol. 32 Issue 11, p1532 

    Presents a study which investigated the correlation between antifungal prophylaxis and bacteremia in febrile neutropenia. Patients and methods; Results and discussion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics